Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-24-196975
Filing Date
2024-08-08
Accepted
2024-08-08 16:13:36
Documents
16
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A d877835d10qa.htm   iXBRL 10-Q/A 60710
2 EX-31.1 d877835dex311.htm EX-31.1 3979
  Complete submission text file 0001193125-24-196975.txt   248209

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vor-20240331.xsd EX-101.SCH 4580
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vor-20240331_cal.xml EX-101.CAL 663
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vor-20240331_def.xml EX-101.DEF 14354
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20240331_lab.xml EX-101.LAB 19592
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20240331_pre.xml EX-101.PRE 15525
18 EXTRACTED XBRL INSTANCE DOCUMENT d877835d10qa_htm.xml XML 7033
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39979 | Film No.: 241188489
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)